Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd-Rüdiger Balda
Michael Hertl

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
The Journal of Investigative Dermatology|April 10, 2017
Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016Enno Schmidt, Volker Spindler, Rüdiger Eming, et al.
Orphanet Journal of Rare Diseases|May 20, 2021
Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in GermansChristian Schwarm, Damian Gola, Maike M Holtsche, et al.
Journal of the American Academy of Dermatology|March 15, 2008
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigusDedee F Murrell, Sarah Dick, A R Ahmed, et al.
Signal Transduction and Targeted Therapy|February 2, 2026
Wnt-associated DKK3 in keratinocytes mediates radiation-induced hyperplasia, dermatitis and skin fibrosisLi Li, Ramon Lopez Perez, Khuram Shehzad, et al.
The British Journal of Dermatology|August 12, 2025
Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of desmoglein 3-peptide-coupled tolerizing nanoparticles in pemphigusDario Didona, Christoph Hudemann, Holger Garn, et al.
Journal of the American Academy of Dermatology|November 8, 2011
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of expertsDedee F Murrell, Benjamin S Daniel, Pascal Joly, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of expertsDedee F Murrell, Branka Marinovic, Frederic Caux, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
The Journal of Investigative Dermatology|October 11, 2018
Large International Validation of ABSIS and PDAI Pemphigus Severity ScoresVivien Hébert, Claire Boulard, Estelle Houivet, et al.
Journal of the American Academy of Dermatology|February 14, 2018
Diagnosis and management of pemphigus: Recommendations of an international panel of expertsDedee F Murrell, Sandra Peña, Pascal Joly, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
The Journal of Investigative Dermatology|April 10, 2017
Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016Enno Schmidt, Volker Spindler, Rüdiger Eming, et al.
Orphanet Journal of Rare Diseases|May 20, 2021
Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in GermansChristian Schwarm, Damian Gola, Maike M Holtsche, et al.
Journal of the American Academy of Dermatology|March 15, 2008
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigusDedee F Murrell, Sarah Dick, A R Ahmed, et al.
Signal Transduction and Targeted Therapy|February 2, 2026
Wnt-associated DKK3 in keratinocytes mediates radiation-induced hyperplasia, dermatitis and skin fibrosisLi Li, Ramon Lopez Perez, Khuram Shehzad, et al.
The British Journal of Dermatology|August 12, 2025
Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of desmoglein 3-peptide-coupled tolerizing nanoparticles in pemphigusDario Didona, Christoph Hudemann, Holger Garn, et al.
Journal of the American Academy of Dermatology|November 8, 2011
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of expertsDedee F Murrell, Benjamin S Daniel, Pascal Joly, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of expertsDedee F Murrell, Branka Marinovic, Frederic Caux, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
The Journal of Investigative Dermatology|October 11, 2018
Large International Validation of ABSIS and PDAI Pemphigus Severity ScoresVivien Hébert, Claire Boulard, Estelle Houivet, et al.
Journal of the American Academy of Dermatology|February 14, 2018
Diagnosis and management of pemphigus: Recommendations of an international panel of expertsDedee F Murrell, Sandra Peña, Pascal Joly, et al.
Pageof 18